Considering the heterogeneity of the two CRC cells on GPX4 expression, our research indicates an increase in lipid peroxidation with combined treatment, alongside a downregulation of the xCT expression compared to MET treatment alone when combined with CUR. The gene discussed is SLC7A11; the disease is colorectal carcinoma.